| abstract |
The present application relates to new heteroaryl-substituted pyrazolopyridines, to processes for preparing them, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and also to their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, more particularly for the treatment and/or prophylaxis of cardiovascular diseases. |